AUC passes, Cmax fails: biopharmaceutical difference [PK / PD]

posted by Helmut Homepage – Vienna, Austria, 2021-03-23 11:03 (422 d 09:01 ago) – Posting: # 22292
Views: 876

Merhaba akif,

» I want to know that why while auc with in spect Cmax out of it? its means that test has higher dissolution rate everytime, …

Only if your drug is in BCS class I or – under certain conditions – in class III, dissolution plays a major rule. If in class II/IV, dissolution is not predictive. There are a manifold of reasons with the absorption rate differs between products. Even if excipients and their amount are identical, differences in the manufacturing process may explain the different absorption.

» … or can cause another thing such as CRO, …

No.

» … design of study, …

Only if you have problems with a “first point Cmax”.

» … bioanalytical method?

No.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,085 posts in 4,629 threads, 1,566 registered users;
online 12 (0 registered, 12 guests [including 10 identified bots]).
Forum time: Thursday 21:05 CEST (Europe/Vienna)

That which is not controversial
is of no particular interest.    Johann Wolfgang von Goethe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5